首页> 外文期刊>Rice World >What's the future of
【24h】

What's the future of

机译:未来是什么

获取原文
获取原文并翻译 | 示例
       

摘要

During the recent session of the Arkansas legislature, competing bills were introduced to regulate plant-made pharmaceutical crops in the state. The first, Senate Bill 318 (SB318), called for a ban, with rare exceptions, on growing plant-made Pharmaceuticals. It didn't make it out of the Senate Agriculture Committee. The second, House Bill 2574 (HB2574), was more lenient toward such crops. After several weeks of debate, HB2574 passed the legislature. At the time, there was much speculation that agricultural researchers in the state had been closely involved with HB2574. Bill Reed, Riceland Foods vice president, confirmed that in a mid-March interview. "The industry -Farm Bureau, Arkansas Rice Producers, the Southern Crop Production Association, theuniversity research divisions, the Arkansas Plant Board and others - put together a bill we believe provides a balanced approach to this situation."
机译:在最近的阿肯色州议会会议期间,提出了竞争性法案,以规范该州的植物性药用作物。第一项法案是参议院第318号法案(SB318),该法案要求除极少数例外,禁止种植植物性药物。它没有脱离参议院农业委员会。第二个是2574号房屋法案(HB2574),对此类农作物更为宽容。经过数周的辩论,HB2574通过了立法机关。当时,很多人猜测该州的农业研究人员与HB2574密切相关。 Riceland Foods副总裁Bill Reed在3月中旬的采访中证实了这一点。 “该行业-农业局,阿肯色州稻米生产者,南方农作物生产协会,大学研究部门,阿肯色州植物委员会及其他机构-共同制定了一项法案,我们认为该法案为解决这种情况提供了一种平衡的方法。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号